Galanin-R1 receptor in anterior and mid-hypothalamus: distribution and regulation.
The distribution and regulation of galanin-R1 receptor (GAL-R1-R) mRNA has been studied in the anterior and mid-diencephalon by using in situ hybridization. Moreover, possible colocalization of GAL-R1-R mRNA and prepro-galanin or vasopressin mRNAs has been analyzed at the cellular level using double in situ hybridization methodology. Many nuclei in the hypothalamus expressed GAL-R1-R mRNA, including the paraventricular nucleus (PVN) and the supraoptic nucleus (SON). Strong expression was also seen in the same sections in various areas outside of the diencephalon. The distribution patterns are similar to those described in earlier studies. Double labeling experiments showed GAL-R1-R mRNA in vasopressin neurons in the PVN and SON. Moreover, GAL-R1-R mRNA and prepro-galanin mRNA were colocalized in several hypothalamic nuclei. GAL-R1-R mRNA levels showed a high degree of plasticity. Thus, salt loading resulted in a marked increase in GAL-R1-R mRNA levels in the PVN and SON and a moderate decrease was seen during lactation. In contrast, hypophysectomy caused a decrease in GAL-R1-R mRNA levels. Differential effects of colchicine were recorded with a decrease of GAL-R1-R mRNA in the magnocellular hypothalamic neurons. After salt loading or during lactation, GAL-R1-R mRNA and prepro-galanin mRNA were regulated in parallel, whereas their levels changed in opposite directions after hypophysectomy and colchicine injection. In conclusion, GAL-R1-Rs are present in several hypothalamic nuclei, partly in neurons synthesizing galanin. The receptors are regulated in a specific fashion in the various nuclei, depending on the stimulus applied. The results suggest that the effect of galanin in the hypothalamus partly depends on the state of receptor expression.
Landry
M
M
Department of Neuroscience, Karolinska Institute, Stockholm, Sweden. marc.landry@biocell.u-bordeaux2.fr
Aman
K
K
Hökfelt
T
T
D000818:Animals; D003078:Colchicine; D005260:Female; D019204:GTP-Binding Proteins / Q000032:analysis; D019004:Galanin / Q000235:genetics; D015870:Gene Expression / Q000502:physiology; D006982:Hypertonic Solutions / Q000494:pharmacology; D007016:Hypophysectomy; D007033:Hypothalamus, Middle / Q000737:chemistry* / Q000166:cytology / Q000601:surgery; D017403:In Situ Hybridization; D007774:Lactation / Q000502:physiology; D008297:Male; D009474:Neurons / Q000737:chemistry; D010121:Oxytocin / Q000235:genetics; D010286:Paraventricular Hypothalamic Nucleus / Q000737:chemistry; D012333:RNA, Messenger / Q000032:analysis; D051381:Rats; D017207:Rats, Sprague-Dawley; D044088:Receptors, Galanin; D018013:Receptors, Neuropeptide / Q000032:analysis* / Q000235:genetics*; D012965:Sodium Chloride / Q000494:pharmacology; D013495:Supraoptic Nucleus / Q000737:chemistry; D014667:Vasopressins / Q000235:genetics; D014882:Water-Electrolyte Balance / Q000187:drug effects / Q000502:physiology
D006982:Hypertonic Solutions; D012333:RNA, Messenger; D044088:Receptors, Galanin; D018013:Receptors, Neuropeptide; D014667:Vasopressins; D012965:Sodium Chloride; D010121:Oxytocin; D019004:Galanin; D019204:GTP-Binding Proteins; D003078:Colchicine